Clinical trial
Turkey Metabolic Syndrome Prevalence Study - METSAR II
NCT02379702 is registered in ClinicalTrials.gov with Abdi Ibrahim Ilac San. ve Tic A.S. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Turkey Metabolic Syndrome Prevalence Study - METSAR II
- Lead sponsor
- Abdi Ibrahim Ilac San. ve Tic A.S.
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- November 30, 2014
- Enrollment
- 1,659 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.